Hosted on MSN1mon
Beam presents new NHP data demonstrating proof-of-concept for ESCAPE
Beam Therapeutics (BEAM) announced new data for its Engineered Stem Cell Antibody Evasion, or ESCAPE, conditioning platform. Presented in an oral session at the 66th American Society of Hematology ...
CNN1y
Beam Therapeutics, Inc.
Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor ...